Literature DB >> 20336353

In vitro biocompatibility and corrosion resistance of a new implant titanium base alloy.

E Vasilescu1, P Drob, D Raducanu, V D Cojocaru, I Cinca, D Iordachescu, R Ion, M Popa, C Vasilescu.   

Abstract

One objective of this work was to study the corrosion resistance of the new implant Ti-10Zr-5Ta-5Nb alloy in physiological fluids of different pH values, simulating the extreme functional conditions. Another objective was in vitro biocompatibility evaluation of the new alloy using human fetal osteoblast cell line hFOB 1.19. Cytocompatibility was assessed by determination of possible material cytotoxic effects, cell morphology and cell adhesion. The thermo-mechanical processing of the new implant alloy consisted in plastic deformation (almost 90%) performed by hot rolling accompanied by an initial and final heat treatment. The new Ti-10Zr-5Ta-5Nb alloy presented self-passivation, with a large passive potential range and low passive current densities, namely, a very good anticorrosive resistance in Ringer solution of acid, neutral and alkaline pH values. Cell viability was not affected by the alloy substrate presence and a very good compatibility was noticed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336353     DOI: 10.1007/s10856-010-4057-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  28 in total

1.  Qualitative and quantitative study of human osteoblast adhesion on materials with various surface roughnesses.

Authors:  K Anselme; M Bigerelle; B Noel; E Dufresne; D Judas; A Iost; P Hardouin
Journal:  J Biomed Mater Res       Date:  2000-02

2.  Surface analysis of Ti-15Zr-4Nb-4Ta alloy after implantation in rat tibia.

Authors:  Y Okazak; E Nishimura; H Nakada; K Kobayashi
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

3.  Structure of the interface between rabbit cortical bone and implants of gold, zirconium and titanium.

Authors:  P Thomsen; C Larsson; L E Ericson; L Sennerby; J Lausmaa; B Kasemo
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

Review 4.  Extracellular matrix and integrin signalling: the shape of things to come.

Authors:  N J Boudreau; P L Jones
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

5.  Monitoring of titanium base alloys-biofluids interface.

Authors:  M V Popa; I Demetrescu; S-H Suh; E Vasilescu; P Drob; D Ionita; C Vasilescu
Journal:  Bioelectrochemistry       Date:  2007-03-06       Impact factor: 5.373

6.  In vitro corrosion resistance of titanium made using different fabrication methods.

Authors:  Z Cai; H Nakajima; M Woldu; A Berglund; M Bergman; T Okabe
Journal:  Biomaterials       Date:  1999-01       Impact factor: 12.479

7.  Surface modification of implant materials and its effect on attachment and proliferation of bone cells.

Authors:  Hak-Kwan Kim; Ju-Woong Jang; Chang-Hee Lee
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

8.  Development of a beta-type Ti-12Mo-5Ta alloy for biomedical applications: cytocompatibility and metallurgical aspects.

Authors:  D M Gordin; T Gloriant; G Texier; I Thibon; D Ansel; J L Duval; M D Nagel
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

9.  In vitro corrosion of Ti-6Al-4V and type 316L stainless steel when galvanically coupled with carbon.

Authors:  N G Thompson; R A Buchanan; J E Lemons
Journal:  J Biomed Mater Res       Date:  1979-01

10.  Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.

Authors:  S Miyamoto; H Teramoto; O A Coso; J S Gutkind; P D Burbelo; S K Akiyama; K M Yamada
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

View more
  1 in total

1.  Surface characterization and biocompatibility of titanium alloys implanted with nitrogen by Hardion+ technology.

Authors:  D M Gordin; T Gloriant; V Chane-Pane; D Busardo; V Mitran; D Höche; C Vasilescu; S I Drob; A Cimpean
Journal:  J Mater Sci Mater Med       Date:  2012-08-24       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.